Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes

Archives of Virology

Volumn 156, Issue 3, 2011, Pages 433-442

  Khaliq, Saba ^a   Jahan, Shah ^a   Ijaz, Bushra ^a   Ahmad, Waqar ^a   Asad, Sultan ^a   Hassan, Sajida ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

E1 PROTEIN, HEPATITIS C VIRUS; GLYCOPROTEIN E2, HEPATITIS C VIRUS; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; BIOSYNTHESIS; CELL LINE; CLASSIFICATION; DNA SEQUENCE; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HEPATITIS C VIRUS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAKISTAN;

CELL LINE; GENE EXPRESSION; GENOTYPE; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PAKISTAN; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 3;

EID: 79952251325     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0887-6     Document Type: Article

References (61)

1. Parker SP, Khan HI, Cubitt WD (1999) Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. J Clin Microbiol 37:2061-2063
2. Giannini C, Brechot C (2003) Hepatitis C virus biology. Cell Death Differ 10:S27-S38
3. Alter MJ (1997) Epidemiology of hepatitis C. Hepatology 3:62S-65S.
4. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36(5):S21-S29
5. Idrees M, Riazuddin S (2008) Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 8:69
6. Ahmad W, Ijaz B, Javed FT, Jahan S, Shahid I, Khan FM, Hassan S (2010) HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J Gastroenterol 16:4321-4328
7. Idrees M, Rafique S, Rehman I, Akbar H, Yousaf MZ, Butt S, Awan Z, Manzoor S, Akram M, Aftab M, Khubaib B, Riazuddin S (2009) Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World J Gastroenterol 15:5080-5085
8. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358:958-965
9. Dubuisson J, Rice CM (1996) Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. J Virol 70:778-786
10. Op De Beeck A, Voisset C, Bartosch B, Ciczora Y, Cocquerel L, Keck Z, Foung S, Cosset FL, Dubuisson J (2004) Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78:2994-3002
11. Bartosch B, Dubuisson J, Cosset FL (2003) Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633-642
12. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791-796
13. Lavie M, Goffard A, Dubuisson J (2007) Assembly of a functional HCV glycoprotein heterodimer. Curr Issues Mol Biol 9:71-86
14. Goffard A, Dubuisson J (2003) Glycosylation of hepatitis C virus envelope proteins. Biochemie 85:295-301
15. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA (2004) CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78:1448-1455
16. Garry RF, Dash S (2003) Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. Virology 307:255-265
17. Flint M, Logvinoff C, Rice CM, McKeating JA (2004) Characterization of infectious retroviral pseudotype particles bearing hepatitis- C virus glycoproteins. J Virol 78:6875-6882
18. Lavillette D, Pecheur EI, Donot P, Fresquet J, Molle J, Corbau R, Dreux M, Penin F, Cosset FL (2007) Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J Virol 81:8752-8765
19. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282:938-941
20. Meola A, Sbardellati A, Bruni EB, Cerretani M, Pezzanera M, Ceccacci A, Vitelli A, Levy S, Alfredo N, Traboni C, McKeating J, Scarselli E (2000) Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol 74:5933-5938
21. Cocquerel L, Kuo CC, Dubuisson J, Levy S (2003) CD81- dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 77(19):10677-10683
22. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature 391:806-811
23. Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000) RNAi: double- stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33
24. Hammond SM, Bernstein E, Beach D, Hannon GJ (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293-296
25. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200
26. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20:6877-6888
27. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
28. Sharp PA (2001) RNA interference-2001. Genes Dev 15:485-490
29. Hannon GJ (2002) RNA interference. Nature 418:244-251
30. Cullen BR (2002) RNA interference: antiviral defense and genetic tool. Nat Immunol 3:597-599
31. Paddison PJ, Hannon GJ (2002) RNA interference: the new somatic cell genetics? Cancer Cell 2:17-23
32. Seo MY, Abrignani S, Houghton M, Han JH (2003) Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J Virol 77:810-812
33. Kapadia SB, Brideau-Andersen A, Chisari FV (2003) Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci 100:2014-2018
34. Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S, Sarangi F, Harris-Brandts M, Beaulieu S, Richardson CD (2003) RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci 100:2783-2788
35. Randall G, Grakoui A, Rice CM (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci 100:235-240
36. Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S, Yi L, Kurosaki M, Taira K, Watanabe M, Mizusawa H (2003) Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 4:602-608
37. Kronke J, Kittler R, Buchholz F, Windisch MP, Pietschmann T, Bartenschlager R, Frese M (2004) Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol 78:3436-3446
38. Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, Robichaux WH, Dash S (2005) Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full length hepatitis C virus clone. J Med Virol 76:511-519
39. Liu M, Ding H, Zhau P, Qin ZL, Gao J, Cao MM, Luan J, Wu WB, Qi ZT (2006) RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. Biosci Biotechnol Biochem 70:2049-2055
40. Kanda T, Steele R, Ray R, Ray RB (2007) Small interfering RNA targeted to hepatitis C virus 5' nontranslated regions exerts potent antiviral effect. J Virol 81:669-676
41. el-Awady MK, Tabll AA, el-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, Bader el-Din NG, Redwan el RM, el-Demellawy M, Omran MH, el-Garf WT, Goueli SA (2006) HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gasteroentrol 12:4836-4842
42. Zekri AR, Bahnassy AA, El-Din HM, Salama HM (2009) Consensus siRNA for inhibition of HCV genotype-4 replication. Virol J 6:13
43. Kim M, Shin D, Kim SI, Park M (2006) Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tricistronic full-length viral replicon and a transient mouse model. Virus Res 122:1-10
44. Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT (2005) Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology 41:660-667
45. Helle F, Wychowski C, Vu-Dac N, Gustafson KR, Voisset C, Dubuisson J (2006) Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope glycans. J Biol Chem 282:25177-25183
46. Goffard A, Callen N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J (2005) Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 79:8400-8409
47. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM (2005) Complete replication of hepatitis C virus in cell culture. Science 309:623-626
48. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci 102: 9294-9299
49. Guha C, Lee SW, Chowdhury NR, Chowdhury JR (2005) Part II: hepatitis C. Lab Anim 34:39-47
50. Lazaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW, Fausto N (2007) Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 170:478-489
51. Buck M (2008) Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS One 3:e2660
52. Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, Sureau C, Fabre JM, Sacunha A, Larrey D, Dubuisson J, Coste J, McKeating J, Maurel P, Fournier-Wirth C (2008) Serum derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 82:569-574
53. Wilson JA, Richardson CD (2005) Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5B coding region. J Virol 79:7050-7058
54. Watanabe T, Umehara T, Yasui F, Nakagawa S, Yano J, Ohgi T, Sonoke S, Satoh K, Inoue K, Yoshiba M, Kohara M (2007) Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. J Hepatol 47:744-750
55. De Francesco R, Migliaccio G (2005) Challenges and successes in developing new therapies for hepatitis C virus. Nature 436:953-960
56. Korf M, Meyer A, Jarczak D, Beger C, Manns MP, Kruger M (2007) Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters. J Virol Hepat 14:122-132
57. Bian T, Zhou Y, Bi S, Tan W, Wang Y (2009) HCV envelope protein function is dependent on the peptides preceding the glycoproteins. Biochem Biophys Res Commun 378:118-122
58. Shin D, Lee H, Kim SI, Yoon Y, Kim M (2009) Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus. RNA 15:898-910
59. Morrica A, Giorgi M, Maggi F, Fornai C, Vatteroni ML, Marchi S, Ricchiuti A, Antonelli G, Pistello M, Bendinelli M (1999) Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method. J Virol Methods 77:207-215
60. Ho YT, Wu SL, Lai IL, Cheng KS, Kao ST, Hsiang CY (2003) An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitors. Antiviral Res 58:199-208
61. Pan Q, Henry SD, Metselaar HJ, Scholte B, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ (2009) Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing. J Mol Med 87:713-722